Evidence map›Paper›PMID 32872778›Full record

ArticleAnalytical chemistry2020

Single-Peptide TR-FRET Detection Platform for Cysteine-Specific Post-Translational Modifications.

Ville Eskonen, Natalia Tong-Ochoa, Leena Mattsson, Moona Miettinen, Mika Lastusaari, Arto T Pulliainen, Kari Kopra, Harri Härmä

Abstract read
In one paragraph

Article in Analytical chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ville EskonenChemistry of Drug Development, Department of Chemistry, University of Turku, Vatselankatu 2, FI-20014 Turku, Finland.ORCID 0000-0001-5214-5904
Natalia Tong-OchoaChemistry of Drug Development, Department of Chemistry, University of Turku, Vatselankatu 2, FI-20014 Turku, Finland.
Leena MattssonChemistry of Drug Development, Department of Chemistry, University of Turku, Vatselankatu 2, FI-20014 Turku, Finland.
Moona MiettinenInstitute of Biomedicine, University of Turku, Kiinamyllynkatu 10, 20520 Turku, Finland.
Mika LastusaariInorganic Materials Chemistry Research Group, Department of Chemistry, University of Turku, Vatselankatu 2, FI-20014 Turku, Finland.ORCID 0000-0003-1872-0391
Arto T PulliainenInstitute of Biomedicine, University of Turku, Kiinamyllynkatu 10, 20520 Turku, Finland.ORCID 0000-0002-9361-8963
Kari KopraChemistry of Drug Development, Department of Chemistry, University of Turku, Vatselankatu 2, FI-20014 Turku, Finland.ORCID 0000-0001-7585-6020
Harri HärmäChemistry of Drug Development, Department of Chemistry, University of Turku, Vatselankatu 2, FI-20014 Turku, Finland.ORCID 0000-0002-8936-039X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Post-translational modifications (PTMs) are one of the most important regulatory mechanisms in cells, and they play key roles in cell signaling both in health and disease. PTM catalyzing enzymes have become significant drug targets, and therefore, tremendous interest has been focused on the development of broad-scale assays to monitor several different PTMs with a single detection platform. Most of the current methodologies suffer from low throughput or rely on antibody recognition, increasing the assay costs, and decreasing the multifunctionality of the assay. Thus, we have developed a sensitive time-resolved Förster resonance energy transfer (TR-FRET) detection method for PTMs of cysteine residues using a single-peptide approach performed in a 384-well format. In the developed assay, the enzyme-specific biotinylated substrate peptide is post-translationally modified at the cysteine residue, preventing the subsequent thiol coupling with a reactive AlexaFluor 680 acceptor dye. In the absence of enzymatic activity, increase in the TR-FRET signal between the biotin-bound Eu(III)-labeled streptavidin donor and the cysteine-coupled AlexaFluor 680 acceptor dye is observed. We demonstrate the detection concept with cysteine modifying S-nitrosylation and ADP-ribosylation reactions using a chemical nitric oxide donor S-nitrosoglutathione and enzymatic ADP-ribosyltransferase PtxS1-subunit of pertussis toxin, respectively. As a proof of concept, three peptide substrates derived from the small GTPase K-Ras and the inhibitory α-subunit of the heterotrimeric G-protein Gαi showed expected functionality in both chemical and enzymatic assays. Measurements yielded signal-to-background ratios of 28.7, 33.0, and 8.7 between the modified and the nonmodified substrates for the three peptides in the S-nitrosylation assay, 5.8 in the NAD

Indexed as

Fluorescence Resonance Energy TransferCysteineHumansPeptidesProtein Processing, Post-TranslationalCysteinePeptides

Identifiers

PMID32872778
PMCPMC7735653

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.